Shi, Yaqin <br/><br/>
DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors.  [electronic resource] 

 -  Neoplasia (New York, N.Y.)  06 2019 
 - 533-544 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5586 
<br/><br/><label>Standard No.: </label>10.1016/j.neo.2019.04.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--antagonists & inhibitors<br/>Animals<br/>Benzimidazoles--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Co-Repressor Proteins<br/>DNA Damage--drug effects<br/>DNA Repair--drug effects<br/>Female<br/>Heterografts<br/>Humans<br/>Mice<br/>Molecular Chaperones<br/>Morpholines--pharmacology<br/>Nuclear Proteins--antagonists & inhibitors<br/>Poly (ADP-Ribose) Polymerase-1--genetics<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Promoter Regions, Genetic--drug effects<br/>Pyrroles--pharmacology<br/>Rad51 Recombinase--genetics<br/>Triple Negative Breast Neoplasms--drug therapy<br/>Tumor Suppressor Proteins--antagonists & inhibitors